Regeneron Pharmaceuticals Inc.
REGN | NASDAQ
$797.13
+$12.46 (+1.59%)
Sep 21, 2026, 12:44 PM ET · Market open
Market Data
Market Cap $80.84B
Enterprise Value $80.86B
Beta 0.24
Average Volume 931.29K
Shares Outstanding (Diluted) 106.8M
Shares Change YoY -1.66%
Institutional Ownership 85.39%
Exchange NASDAQ
ISIN US75886F1075
Price Performance
Price Change 1M -4.0%
Price Change 3M 28.1%
Price Change 6M 6.6%
Price Change YTD 1.1%
Price Change 1Y 31.1%
Price Change 3Y -4.8%
Price Change 5Y 22.8%
1M CAGR (ann.) 1.8%
1Y CAGR (ann.) 34.7%
5Y CAGR (ann.) 4.0%
All-Time CAGR 20.4%
Valuation
PE Ratio 19.41
Forward PE 12.25
PEG Ratio 60.17
Forward PEG 1.52
PS Ratio 5.20
Forward PS 4.30
PB Ratio 2,549,771.27
P/FCF Ratio 22.96
P/Adj. FCF Ratio 31.89
P/OCF Ratio 18.27
EV/Sales 5.20
EV/EBIT 16.93
EV/EBITDA 15.99
EV/FCF 22.96
Earnings Yield 5.2%
FCF Yield 4.4%
Adj. FCF Yield 3.1%
Financial Health
Net Cash $6.01K
Total Debt $1.99K
Cash & Short-Term Investments $7.99K
Total Assets $41.73K
Current Ratio 3.34
Quick Ratio 2.78
Debt / Equity Ratio 0.06
Debt / EBITDA 0.00
Debt / FCF 0.00
OCF / Debt 2,236,383.77
Interest Coverage 71.66
Altman Z-Score 5,962,238.52
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 84.9%
Operating Profit Margin 24.7%
EBITDA Margin 37.0%
Net Profit Margin 27.9%
FCF Margin 22.7%
Adj. FCF Margin 16.3%
SBC / Revenue 6.3%
SBC Impact (per share) -28.0%
Returns
Return on Assets 10.4%
Return on Equity 13.8%
Return on Invested Capital 9.2%
Return on Capital Employed 11.0%
Return on Tangible Assets 10.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.0%
Revenue CAGR 5Y 4.6%
Revenue CAGR 10Y 12.8%
EPS CAGR 3Y 2.2%
EPS CAGR 5Y -6.2%
EPS CAGR 10Y 20.2%
FCF CAGR 3Y -5.3%
FCF CAGR 5Y 15.8%
FCF CAGR 10Y 12.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 49
EPS Growth Next 3Y 21.8%
Revenue Growth Next 3Y 11.2%
Earnings Date Oct 27, 2026
EPS Estimate (next Q) $15.99
EPS Growth Est (next Q) 35.2%
Revenue Est (next Q) $4.54B
Revenue Growth Est (next Q) 21.0%
Fair Value Estimates
Graham Number $528.18
Graham Upside -32.7%
Lynch Fair Value $202.15
Lynch Upside -74.2%
Price Target $827.71
Price Target Upside 5.5%
Cash Flow
Operating Cash Flow $4.44B
Free Cash Flow $3.52B
Adj. Free Cash Flow $2.54B
FCF Per Share $34.06
OCF Per Share $42.97
OCF/S Ratio 28.6%
Income Statement
Revenue $15.53B
Gross Profit $12.95B
Operating Income $3.84B
EBITDA $5.06B
Net Income $4.33B
EPS (Diluted) $40.43
Revenue / Employee $1.01M
Profit / Employee $280.9K
Employees 15,410
Dividends
Annual Dividend $3.70
Dividend Yield 0.47%
Payout Ratio 9.2%
FCF Payout Ratio 10.8%
Adj. FCF Payout Ratio 14.9%
Dividend Growth (YoY) 40.1%
Pay Frequency Quarterly
Ex-Dividend Date Aug 17, 2026
Add to Watchlist
Select watchlists to add or remove REGN